Skip to Menu Skip to Search Contact Us Skip to Content
US Flag

You are accessing SGS’s website from the USA.

Visit the US website instead

Stay on the global website and remember my choice

Academic Collaboration with Contract Research Organizations

In the past 15 years there has been a growing trend for universities to spin-out biotech companies and to develop in-house drug discovery capabilities.

An academic group or early spin-off company will encounter many challenges in bringing a compound from the laboratory to clinical development. As is well-documented, drug discovery and development is a lengthy, complex, and costly process, entrenched with a high degree of uncertainty that a drug will actually succeed to reach patients. Indeed, it has been estimated that it now costs around $2.6 billion to develop a new drug, and on average it can take up to 12 years to enter the market.

In this document we explore the benefits of working with an experienced Contract Research Organization.

Please complete the form to download your copy.

Fields marked with an asterisk (*) are mandatory.

White paper request form

Are you an SGS client?*

200 characters remaining